Literature DB >> 11742580

Cardiac toxicity of resibufogenin: electrophysiological evidence.

J T Xie1, L Dey, J A Wu, T K Lowell, C S Yuan.   

Abstract

Resibufogenin (RBG) is a single compound isolated from Chansu, a traditional Chinese medicine obtained from the skin venom gland of the toad. Formulations of Chansu have been widely applied in China, Japan, and other Asian countries for a long time and are currently used as alternative medicines. However, there have been several reports about the toxicity of Chansu and its medical formulations in the United States recently. As digitalis, RBG possesses both pharmacologic and toxicologic effects. According to our study results, RBG, one of major ingredient of Chansu, induced delayed afterdepolarization and triggered arrhythmias both in cardiac fiber in vitro and in beating heart in vivo at the high concentrations. The electrophysiologic toxic effects of RBG, the possible mechanism of toxicity, and treatment possibilities are discussed in the present review

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742580

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  5 in total

Review 1.  Angel of human health: current research updates in toad medicine.

Authors:  Qian Yang; Xuanxuan Zhou; Meng Zhang; Linlin Bi; Shan Miao; Wei Cao; Yanhua Xie; Jiyuan Sun; Haifeng Tang; Ying Li; Qing Miao; Siwang Wang
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

2.  Resibufogenin and cinobufagin activate central neurons through an ouabain-like action.

Authors:  Ze-Jun Wang; Liqin Sun; Thomas Heinbockel
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

3.  Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.

Authors:  Qiuchen Chu; Hong Xu; Meng Gao; Xin Guan; Hongyan Liu; Sa Deng; Xiaokui Huo; Kexin Liu; Yan Tian; Xiaochi Ma
Journal:  Int J Nanomedicine       Date:  2016-01-27

Review 4.  Novel Strategies for Solubility and Bioavailability Enhancement of Bufadienolides.

Authors:  Huili Shao; Bingqian Li; Huan Li; Lei Gao; Chao Zhang; Huagang Sheng; Liqiao Zhu
Journal:  Molecules       Date:  2021-12-22       Impact factor: 4.411

5.  Promising galactose-decorated biodegradable poloxamer 188-PLGA diblock copolymer nanoparticles of resibufogenin for enhancing liver cancer therapy.

Authors:  Hao Dong; Li Tian; Meng Gao; Hong Xu; Chenghong Zhang; Li Lv; Jianbin Zhang; Changyuan Wang; Yan Tian; Xiaochi Ma
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.